103 related articles for article (PubMed ID: 15257126)
1. Caduet treats two cardiovascular conditions at once.
Wimett L; Laustsen G
Nurse Pract; 2004 Jun; 29(6):56-7. PubMed ID: 15257126
[No Abstract] [Full Text] [Related]
2. A closer look at Caduet. The new generation of combination treatment.
Brock CM; Pitcock J
Adv Nurse Pract; 2005 Jan; 13(1):31-3. PubMed ID: 15679289
[No Abstract] [Full Text] [Related]
3. Amlodipine/atorvastatin (Caduet).
Med Lett Drugs Ther; 2004 Jul; 46(1186):56. PubMed ID: 15237282
[No Abstract] [Full Text] [Related]
4. Atorvastatin and amlodipine: the successful duet that led to Caduet.
Cardiovasc J Afr; 2009; 20(1):87-8. PubMed ID: 19287825
[No Abstract] [Full Text] [Related]
5. Amlodipine/atorvastatin: the first cross risk factor polypill for the prevention and treatment of cardiovascular disease.
Frishman WH; Zuckerman AL
Expert Rev Cardiovasc Ther; 2004 Sep; 2(5):675-81. PubMed ID: 15350169
[TBL] [Abstract][Full Text] [Related]
6. Single-pill amlodipine/atorvastatin helps patients of diverse ethnicity attain recommended goals for blood pressure and lipids (the Gemini-AALA study).
Erdine S; Ro YM; Tse HF; Howes LG; Aguilar-Salinas CA; Chaves H; Guindy R; Chopra P; Moller RA; Schou IM;
J Hum Hypertens; 2009 Mar; 23(3):196-210. PubMed ID: 18800143
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous treatment of hypertension and dyslipidaemia may help to reduce overall cardiovascular risk: focus on amlodipine/atorvastatin single-pill therapy.
Cowie MR
Int J Clin Pract; 2005 Jul; 59(7):839-46. PubMed ID: 15963213
[TBL] [Abstract][Full Text] [Related]
8. Slovak trial on cardiovascular risk reduction following national guidelines with CaDUET® (the STRONG DUET study).
Fedacko J; Pella D; Jarcuska P; Sabol F; Kmec J; Lopuchovsky T; Merkovska L; Jedlickova L; Janicko M; Sajty M
Adv Ther; 2013 Jan; 30(1):60-70. PubMed ID: 23328937
[TBL] [Abstract][Full Text] [Related]
9. A randomized, placebo-controlled trial to evaluate the efficacy, safety, and pharmacodynamic interaction of coadministered amlodipine and atorvastatin in 1660 patients with concomitant hypertension and dyslipidemia: the respond trial.
Preston RA; Harvey P; Herfert O; Dykstra G; Jukema JW; Sun F; Gillen D
J Clin Pharmacol; 2007 Dec; 47(12):1555-69. PubMed ID: 18048574
[TBL] [Abstract][Full Text] [Related]
10. Atorvastatin + amlodipine: new drug. Just a commercial ploy.
Prescrire Int; 2007 Jun; 16(89):105. PubMed ID: 17582926
[TBL] [Abstract][Full Text] [Related]
11. Amlodipine/Atorvastatin: a review of its use in the treatment of hypertension and dyslipidaemia and the prevention of cardiovascular disease.
Curran MP
Drugs; 2010; 70(2):191-213. PubMed ID: 20108992
[TBL] [Abstract][Full Text] [Related]
12. A single-pill combination of amlodipine besylate and atorvastatin calcium (update).
Blank R; Hobbs FD; Zamorano J; Girerd X
Drugs Today (Barc); 2007 Mar; 43(3):157-77. PubMed ID: 17380213
[TBL] [Abstract][Full Text] [Related]
13. Design and rationale of a real-life study to compare treatment strategies for cardiovascular risk factors: the CRUCIAL study.
Zamorano J; Erdine S; Lopez AP; Kim JH; Al Khadra A; Westergaard M; Sutradhar S; Yunis C;
Postgrad Med; 2010 Mar; 122(2):7-15. PubMed ID: 20203451
[TBL] [Abstract][Full Text] [Related]
14. Amlodipine/atorvastatin (Caduet) for preventing heart disease.
Wilson SA; Sanford A
Am Fam Physician; 2006 Mar; 73(6):1067-8. PubMed ID: 16570743
[No Abstract] [Full Text] [Related]
15. Can combining different risk interventions into a single formulation contribute to improved cardiovascular disease risk reduction? Rationale and design for an international, open-label program to assess the effectiveness of a single pill (amlodipine/atorvastatin) to attain recommended target levels for blood pressure and lipids (The JEWEL Program).
Hobbs FD; Gensini G; Mancini GB; Manolis AJ; Bauer B; Böhler S; Genest J; Feldman R; Harvey P; Jenssen TG; Metcalfe M; da Silva PM;
Int J Cardiol; 2006 Jun; 110(2):242-50. PubMed ID: 16338012
[TBL] [Abstract][Full Text] [Related]
16. Amlodipine/atorvastatin fixed-dose combination: a review of its use in the prevention of cardiovascular disease and in the treatment of hypertension and dyslipidemia.
McKeage K; Siddiqui MA
Am J Cardiovasc Drugs; 2008; 8(1):51-67. PubMed ID: 18303938
[TBL] [Abstract][Full Text] [Related]
17. Atorvastatin calcium plus amlodipine for the treatment of hypertension.
Delgado-Montero A; Zamorano JL
Expert Opin Pharmacother; 2012 Dec; 13(18):2673-85. PubMed ID: 23140185
[TBL] [Abstract][Full Text] [Related]
18. Fixed combination of amlodipine/atorvastatin: from mechanisms to trials.
Ivanovic B; Tadic M
J Cardiovasc Pharmacol Ther; 2013 Nov; 18(6):544-9. PubMed ID: 23832643
[TBL] [Abstract][Full Text] [Related]
19. Bioavailability of amlodipine besylate/atorvastatin calcium combination tablet.
Chung M; Calcagni A; Glue P; Bramson C
J Clin Pharmacol; 2006 Sep; 46(9):1030-7. PubMed ID: 16920898
[TBL] [Abstract][Full Text] [Related]
20. Results of a Markov model analysis to assess the cost-effectiveness of a single tablet of fixed-dose amlodipine and atorvastatin for the primary prevention of cardiovascular disease in Korea.
Liew D; Park HJ; Ko SK
Clin Ther; 2009 Oct; 31(10):2189-203; discussion 2150-1. PubMed ID: 19922890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
